Caricamento...

Do biological disease-modifying antirheumatic drugs reduce the spinal fracture risk related to ankylosing spondylitis? A longitudinal multiregistry matched cohort study

OBJECTIVES: Ankylosing spondylitis (AS) is associated with an increased spinal fracture risk due to the loss of elasticity in spinal motion segments. With the introduction of biological disease-modifying antirheumatic drug (bDMARD) treatment for AS, the individual course of the disease has been amel...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMJ Open
Autori principali: Robinson, Yohan, Olerud, Claes, Willander, Johan
Natura: Artigo
Lingua:Inglês
Pubblicazione: BMJ Publishing Group 2017
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5770921/
https://ncbi.nlm.nih.gov/pubmed/29288176
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2017-016548
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !